Search

An increasing aging population poses a significant challenge to societies worldwide. A better understanding of the molecular, cellular, organ, tissue, physiological, psychological, and even sociological changes that occur with aging is needed in order to treat age-associated diseases. The field of aging research is rapidly expanding with multiple advances transpiring in many previously disconnected areas. Several major pharmaceutical, biotechnology, and consumer companies made aging research a priority and are building internal expertise, integrating aging research into traditional business models and exploring new go-to-market strategies. Many of these efforts are spearheaded by the latest advances in artificial intelligence, namely deep learning, including generative and reinforcement learning. To facilitate these trends, the Center for Healthy Aging at the University of Copenhagen and Insilico Medicine are building a community of Key Opinion Leaders (KOLs) in these areas and launched the annual conference series titled "Aging Research and Drug Discovery (ARDD)" held in the capital of the pharmaceutical industry, Basel, Switzerland (www.agingpharma.org). This ARDD collection contains summaries from the 6th annual meeting that explored aging mechanisms and new interventions in age-associated diseases. The 7th annual ARDD exhibition will transpire 2nd-4th of September, 2020, in Basel.

Aging is emerging as a druggable target with growing interest from academia, industry and investors. New technologies such as artificial intelligence and advanced screening techniques, as well as a strong influence from the industry sector may lead to novel discoveries to treat age-related diseases. The present review summarizes presentations from the 7th Annual Aging Research and Drug Discovery (ARDD) meeting, held online on the 1st to 4th of September 2020. The meeting covered topics related to new methodologies to study aging, knowledge about basic mechanisms of longevity, latest interventional strategies to target the aging process as well as discussions about the impact of aging research on society and economy. More than 2000 participants and 65 speakers joined the meeting and we already look forward to an even larger meeting next year. Please mark your calendars for the 8th ARDD meeting that is scheduled for the 31st of August to 3rd of September, 2021, at Columbia University, USA., Aging, 12 (24), ISSN:1945-4589

The regeneration of tissues and organs has been a matter of dream and Greek mythology since ancient times as the liver regeneration in Prometheus punished by Zeus. It is now emerging a new way of treating injuries and diseases, which is based on regenerative medicine. Clinical and social needs related to the aging and diseases led to innovative medical therapies that will enable the repairing and regeneration of damaged tissues and organs. This position paper gives a future vision for 2030 of the biohybrid organs and tissues that will be used for patient therapy and in the overcoming the age-related pathologies. The research strategies for the next 20 years will focus on the implantation of bioartificial tissues and the induction of the regeneration. Biomaterials and bioreactor technologies will play pivotal roles in the regeneration and in the production of individualized biological implants. Future challenges will include the development of multifunctional biohybrid organs and tissues. These concepts are based on a multidisciplinary approach bringing together various scientific fields, which will contribute to the new and fascinating medical therapies.